Acutaas Chemicals
Ticker > Company >

Acutaas Chemicals share price

Acutaas Chemicals Ltd.

NSE: AMIORG BSE: 543349 SECTOR: Pharmaceuticals & Drugs  218k   421   83

1199.40
+10.80 (0.91%)
NSE: Today, 09:54 AM

Price Summary

Today's High

₹ 1208

Today's Low

₹ 1181.6

52 Week High

₹ 1322

52 Week Low

₹ 504

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 9819.36 Cr.

Enterprise Value

₹ 9990.14 Cr.

No. of Shares

8.19 Cr.

P/E

61.55

P/B

7.49

Face Value

₹ 5

Div. Yield

0.06 %

Book Value (TTM)

₹  160.21

CASH

₹ 31.94 Cr.

DEBT

₹ 202.73 Cr.

Promoter Holding

35.96 %

EPS (TTM)

₹  19.49

Sales Growth

11.49%

ROE

6.94 %

ROCE

10.22%

Profit Growth

-47.58 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year11.49%
3 Year26.38%
5 Year23.89%

Profit Growth

1 Year-47.58%
3 Year-6.82%
5 Year12.14%

ROE%

1 Year6.94%
3 Year14.37%
5 Year22.38%

ROCE %

1 Year10.22%
3 Year18.26%
5 Year22.9%

Debt/Equity

0.3013

Price to Cash Flow

97.37

Interest Cover Ratio

12.7258

CFO/PAT (5 Yr. Avg.)

0.716888335455604

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 35.96 0.00
Dec 2024 35.96 0.00
Sep 2024 35.97 0.00
Jun 2024 35.98 0.00
May 2024 39.07 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 26.3831279938798% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 12.7258.
  • The company has an efficient Cash Conversion Cycle of 67.5488 days.

 Limitations

  • The company has shown a poor profit growth of -6.82160841094208% for the Past 3 years.
  • The company is trading at a high PE of 61.55.
  • The company is trading at a high EV/EBITDA of 38.955.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 219.94 171.14 243.59 270.94 304.16
Total Expenditure 179.78 144.84 195.46 204.29 220.1
Operating Profit 40.15 26.3 48.13 66.66 84.06
Other Income 8.55 1.9 8.58 2.17 5.69
Interest 2.06 4.37 0.49 0.61 0.38
Depreciation 4.36 5.62 6.2 5.67 6.56
Exceptional Items 0 0 0 0 0
Profit Before Tax 42.29 18.2 50.02 62.54 82.81
Tax 10.21 4.49 12.34 17.24 19.97
Profit After Tax 32.08 13.72 37.68 45.3 62.85
Adjusted EPS (Rs) 4.35 1.68 4.6 5.53 3.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 239.64 340.61 520.14 616.73 687.58
Total Expenditure 198.56 260.41 414.96 494.07 579.92
Operating Profit 41.08 80.2 105.18 122.66 107.67
Other Income 2.77 1.33 2.76 4.32 13.79
Interest 5.59 5.62 6.41 2.41 5.89
Depreciation 3.52 4.19 10.08 12.34 14.69
Exceptional Items 0 0 0 0 -31.75
Profit Before Tax 34.75 71.73 91.45 112.22 69.11
Tax 7.28 17.73 19.5 28.88 25.42
Net Profit 27.47 54 71.95 83.34 43.68
Adjusted EPS (Rs.) 4.36 2.86 9.87 11.44 5.92

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.5 31.5 36.44 36.44 36.88
Total Reserves 97.48 132.45 481.57 550.35 638.23
Borrowings 19.9 72.64 0.59 0.38 113.64
Other N/C liabilities 5.56 7.65 6.7 9.51 14.65
Current liabilities 94.59 166.04 129.31 162.78 267.84
Total Liabilities 228.03 410.29 654.61 759.46 1071.25
Assets
Net Block 62.18 160.61 177.88 222.09 357.06
Capital WIP 11.71 0.2 1.89 25.52 125.42
Intangible WIP 0 0 1.07 4.28 0
Investments 27.89 33.24 33.4 33.45 67.73
Loans & Advances 2.68 1.84 7.78 17.19 48.43
Other N/C Assets 6.97 1.25 5.87 2.21 1.56
Current Assets 116.6 213.14 426.71 454.71 471.05
Total Assets 228.03 410.29 654.61 759.46 1071.25
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 34.75 71.73 91.45 112.22 69.11
Adjustment 7.42 8.87 12.36 11.19 41.84
Changes in Assets & Liabilities -6.51 -39.5 -90.68 -43.23 6.02
Tax Paid -8.41 -14.18 -22.81 -24.45 -16.12
Operating Cash Flow 27.25 26.92 -9.69 55.73 100.85
Investing Cash Flow -24.48 -100.74 -122.47 -20.47 -337.32
Financing Cash Flow 0.19 72.11 140.26 -14.44 235.48
Net Cash Flow 2.96 -1.72 8.1 20.82 -0.99

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 39.91 35.98 35.97 35.96 35.96
nareshkumar ramjibhai pat... 11.60 10.46 10.45 19.34 19.34
vaghasia chetankumar chha... 8.63 7.78 7.78 16.62 16.62
bhanuben chhaganbhai vagh... 0.93 0.84 0.84 - -
chhagan ramjibhai vaghasi... 0.92 0.83 0.83 - -
parulben vaghasia 7.96 7.18 7.18 - -
sheetalben n patel 9.86 8.89 8.89 - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 60.09 64.02 64.03 64.04 64.04
ashish kacholia 2.05 1.85 1.84 1.84 1.72
ashoka whiteoak icav - as... - 1.47 1.47 1.47 1.29
axis max life insurance l... - - - - 2.60
bank of india small cap f... - 1.34 1.71 1.60 1.58
dhwani girishkumar chovat... 3.71 3.35 3.35 3.35 3.35
government of singapore - 1.14 2.05 1.89 1.89
government pension fund g... 2.96 2.67 2.67 2.67 3.35
llp - 0.26 0.24 0.19 0.20
malabar india fund limite... 3.20 2.31 1.81 1.35 1.07
quant mutual fund - quant... - - 1.77 1.96 1.92
sbi large & midcap fund - - 4.32 4.49 4.23
vanaja sundar iyer 1.36 1.22 1.16 1.16 1.16
goldman sachs funds - gol... - - 1.02 1.02 -
max life insurance compan... - 2.44 3.67 3.65 -
tata mutual fund - tata e... 1.04 - - 1.03 -
uti - healthcare fund 1.18 1.04 1.01 - -
kotak mahindra trustee co... - 1.32 - - -
plutus wealth management ... 8.13 4.06 - - -
sbi healthcare opportunit... - 1.28 - - -
morgan stanley asia (sing... 1.00 - - - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Company News

Kotak Mahindra Mutual Fund buys 6.6% stake in Acutaas Chemicals 20 May, 10:30 AM Ami Organics informs about press release 2 May, 5:59 PM Ami Organics informs about audited financial results 2 May, 3:18 PM AMI Organics - Quaterly Results 2 May, 1:10 PM AMI Organics - Quaterly Results 2 May, 1:10 PM AMI Organics - Quaterly Results 2 May, 1:10 PM Ami Organics commissions 10.8 MW DC solar power plant in Gujarat 3 Apr, 5:43 PM AMI Organics informs about press release 3 Apr, 4:41 PM Ami Organics submits analyst meet intimation 22 Feb, 12:19 PM Ami Organics informs about earnings call transcript 1 Feb, 4:05 PM AMI Organics informs about newspaper publication 30 Jan, 5:25 PM Ami Organics informs about statement of deviation or variation 29 Jan, 2:55 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics - Quaterly Results 28 Jan, 5:57 PM AMI Organics informs about closure of trading window 26 Dec, 12:42 PM Ami Organics informs about credit rating 18 Dec, 12:06 PM Ami Organics informs about disclosure 13 Dec, 5:15 PM Ami Organics gets nod to enhance capital expenditure for brownfield project 12 Dec, 10:30 AM AMI Organics informs about conference meet 12 Nov, 5:02 PM Ami Organics informs about statement of deviation or variation 29 Oct, 4:48 PM AMI Organics - Quaterly Results 29 Oct, 12:10 PM AMI Organics - Quaterly Results 29 Oct, 12:10 PM AMI Organics - Quaterly Results 29 Oct, 12:10 PM Ami Organics informs about disclosure 21 Oct, 2:28 PM Ami Organics’ Sachin facility declared as GMP compliant 9 Sep, 11:40 AM AMI Organics informs about investor presentation 12 Aug, 5:31 PM AMI Organics - Quaterly Results 12 Aug, 3:47 PM AMI Organics - Quaterly Results 12 Aug, 3:47 PM AMI Organics - Quaterly Results 12 Aug, 3:47 PM Ami Organics launches QIP with floor price of Rs 1228.71 per share 19 Jun, 11:44 AM Ami Organics informs about audited financial statements 18 Jun, 1:03 PM PMDA Japan concludes GMP inspection of Ami Organics’ manufacturing facility in Surat 8 Jun, 11:23 AM Ami Organics informs about disclosure 7 Jun, 4:19 PM Ami Organics informs about earnings call transcript 17 May, 4:57 PM AMI Organics informs about corporate presentation 16 May, 10:42 AM AMI Organics - Quaterly Results 10 May, 8:51 PM AMI Organics - Quaterly Results 10 May, 8:51 PM Ami Organics informs about board meeting 2 May, 3:07 PM AMI Organics informs about board meeting 2 May, 1:06 PM Ami Organics informs about raising of funds 13 Apr, 11:46 AM AMI Organics informs about investors meet 23 Feb, 12:31 PM Ami Organics informs about transcript of earnings call 16 Feb, 5:01 PM Ami Organics informs about statement of deviation & variation 12 Feb, 5:22 PM AMI Organics - Quaterly Results 12 Feb, 2:33 PM AMI Organics - Quaterly Results 12 Feb, 2:33 PM AMI Organics - Quaterly Results 12 Feb, 2:33 PM AMI Organics informs about commencement of commercial operations 29 Jan, 10:10 AM Ami Organics informs about disclosure 26 Dec, 11:15 AM Ami Organics signs MoU with global manufacturer of Electrolytes 21 Dec, 5:10 PM

Acutaas Chemicals Stock Price Analysis and Quick Research Report. Is Acutaas Chemicals an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Acutaas Chemicals and its performance over the period of time. Acutaas Chemicals stock price today is Rs 1188.8.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Acutaas Chemicals cash from the operating activity was Rs 100.8477 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Acutaas Chemicals has a Debt to Equity ratio of 0.3013 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Acutaas Chemicals , the EPS growth was -48.2141 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Acutaas Chemicals has OPM of 15.6585336837202 % which is a good sign for profitability.
     
  • ROE: Acutaas Chemicals have a poor ROE of 6.9363 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Acutaas Chemicals is Rs 1188.8. One can use valuation calculators of ticker to know if Acutaas Chemicals share price is undervalued or overvalued.
Last Updated on:
Brief about Acutaas Chemicals

AMI Organics Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

AMI Organics Ltd. is a leading Indian company that specializes in the manufacturing and marketing of high-quality pharmaceutical intermediates and specialty chemicals. With a strong foundation of research and development capabilities, the company has been at the forefront of innovation in the industry.

AMI Organics Ltd. - Share Price

The share price of AMI Organics Ltd. is a key metric that investors closely monitor. Our pre-built screening tools enable investors to track the performance of the company's stock over time. By analyzing the share price trends, investors can make informed decisions about buying or selling the stock.

AMI Organics Ltd. - Balance Sheet

The balance sheet of AMI Organics Ltd. provides a snapshot of the company's financial position at a specific point in time. Investors can access the company's annual reports on our website, which include the balance sheet as a downloadable resource. Our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, allow investors to calculate the fair value of the company based on its balance sheet.

AMI Organics Ltd. - Annual Report

The annual report of AMI Organics Ltd. is a comprehensive document that provides insights into the company's financial performance, strategies, and future outlook. Investors can download the annual report from our website to gain a deeper understanding of the company's operations and achievements.

AMI Organics Ltd. - Dividend

Dividends play a significant role in providing returns to stock investors. AMI Organics Ltd. has a track record of rewarding its shareholders with dividends. Investors can find information about the company's dividend history and payout ratios through our stock analysis page. This data, combined with our screening tools, can help investors assess the dividend potential of the company.

AMI Organics Ltd. - Quarterly Result

Tracking the quarterly results of AMI Organics Ltd. is crucial for investors to gauge the company's performance on a regular basis. Our website provides quarterly result updates for the company, allowing investors to analyze trends and make informed decisions. Our premium features can assist investors in conducting a thorough analysis of the company's profit and loss statement.

AMI Organics Ltd. - Stock Price

The stock price of AMI Organics Ltd. reflects the market's perception of the company's value. By analyzing price charts and historical trends, investors can gain insights into the stock's trajectory. Our pre-built screening tools enable investors to track stock price movements and identify potential entry or exit points.

AMI Organics Ltd. - Price Chart

Price charts visually represent the historical performance of AMI Organics Ltd.'s stock. Investors can access price charts on our website, allowing them to monitor stock price movements and identify patterns or trends. Our pre-built screening tools are also available to help investors analyze the price chart data.

AMI Organics Ltd. - News

Staying updated with the latest news about AMI Organics Ltd. is essential for stock investors. Our website provides a dedicated section for news related to the company. By following the news updates, investors can stay informed about important developments and make informed decisions.

AMI Organics Ltd. - Concall Transcripts

For investors seeking deeper insights into AMI Organics Ltd.'s performance and strategy, concall transcripts are a valuable resource. Concall transcripts provide a detailed account of the company's conference calls and discussions with analysts. Investors can download these transcripts from our website to gain a better understanding of the company's outlook and market positioning.

AMI Organics Ltd. - Investor Presentations

Investor presentations offer a comprehensive overview of AMI Organics Ltd.'s business operations, financial performance, and growth prospects. Our website provides downloadable investor presentations, enabling investors to analyze the company's strategy and outlook in detail.

AMI Organics Ltd. - Promoters

Promoters are individuals or entities who play a crucial role in shaping a company's direction and strategy. AMI Organics Ltd. has experienced and dedicated promoters who have contributed to the company's success. Investors can find information about the company's promoters on our website, giving them insight into the people behind the company's growth.

AMI Organics Ltd. - Shareholders

Understanding the shareholder structure of a company is important for investors, as it provides insights into ownership patterns and potential influence. AMI Organics Ltd. has a diverse group of shareholders, including institutional investors and individual retail investors. Investors can access information about the company's major shareholders on our website.

By providing a comprehensive range of information and analysis, our website equips long-term stock investors with the tools they need to make informed decisions about AMI Organics Ltd. Our pre-built screening tools, combined with downloadable resources such as annual reports, concall transcripts, investor presentations, and credit ratings, empower investors to take control of their investment journey.

Read More
X